Horizon Pharma PLC Alpha and Beta Analysis
| HZNPDelisted Stock | USD 100.40 0.13 0.13% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Horizon Pharma PLC. It also helps investors analyze the systematic and unsystematic risks associated with investing in Horizon Pharma over a specified time horizon. Remember, high Horizon Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Horizon Pharma's market risk premium analysis include:
Beta (0.59) | Alpha (0.08) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Horizon |
Horizon Pharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Horizon Pharma market risk premium is the additional return an investor will receive from holding Horizon Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Horizon Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Horizon Pharma's performance over market.| α | -0.08 | β | -0.59 |
Horizon Pharma Fundamentals Vs Peers
Comparing Horizon Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Horizon Pharma's direct or indirect competition across all of the common fundamentals between Horizon Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Horizon Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Horizon Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Horizon Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Horizon Pharma to competition |
| Fundamentals | Horizon Pharma | Peer Average |
| Return On Equity | 0.0854 | -0.31 |
| Return On Asset | 0.0444 | -0.14 |
| Profit Margin | 0.12 % | (1.27) % |
| Operating Margin | 0.18 % | (5.51) % |
| Current Valuation | 26.87 B | 16.62 B |
| Shares Outstanding | 229 M | 571.82 M |
| Shares Owned By Insiders | 1.18 % | 10.09 % |
Horizon Pharma Opportunities
Horizon Pharma Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Horizon Pharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Horizon or other delisted stocks. Alpha measures the amount that position in Horizon Pharma PLC has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Horizon Pharma Upcoming Company Events
As portrayed in its financial statements, the presentation of Horizon Pharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Horizon Pharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Horizon Pharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Horizon Pharma. Please utilize our Beneish M Score to check the likelihood of Horizon Pharma's management manipulating its earnings.
| 1st of November 2023 Upcoming Quarterly Report | View | |
| 6th of March 2024 Next Financial Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 6th of March 2024 Next Fiscal Year End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Horizon Pharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Horizon Stock
If you are still planning to invest in Horizon Pharma PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Horizon Pharma's history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |